City of MEXICO.
There are many myths surrounding the state.
One in three people living with HIV in Latin America is unaware of it, mainly because of the stigma associated with this disease because there is no prevention culture, said Carlos Magis of the National Center for the Prevention and Control of HIV / AIDS (Censida)
"There is still a delay in diagnosis, despite the fact that today a person diagnosed and treated in a timely manner has a high life expectancy," said Magis, director of complete Censida care.
The doctor explained that for current treatments, life expectancy is 40 years in people infected with this virus.
Brenda Crabtree Ramirez, Local Chair of the International AIDS Society (AIDS), pointed out that violence, stigma and inequality in access to prevention and information have become the most important obstacles to overcoming.
"It is a fact that as long as we do not fight against this, the AIDS epidemic can not be effectively attacked," he said.
Experts said that among those with the smallest detection are mainly heterosexual and elderly men.
"Especially in this latter group, it is hard to see that they are at risk because there is a big stigma about this disease," said Juan Sierra, head of the Department of Infecology of the Mexican Institute of Medical Sciences and Nutrition, Salvador Zubirán.
In Mexico, according to Censida data, more than 141,000 people are currently receiving retrovirus treatment and, since 1996, mortality has decreased, although there are still 5,000 annual deaths due to this disease.
"With the treatments we offer at the Ministry of Health, the patients were better and 51% of those diagnosed and treated decreased the viral load at six months," Magis said.
He added that one of the deficiencies in the region is that pharmacy tests are not yet available to the population, which in countries like the United States is available to anyone who wants to get a quick test.
He added that reducing treatment costs would be of great help in countries like Mexico, where spending on HIV treatment takes one third of the catastrophic spending fund of the Seguro population.
Public policies should aim to improve access to treatment and one of the options is to reduce costs, consolidate purchases of medicines and allow more medicines to get to Mexico, he said.
He explained that in regions like Africa, the cost of treatment is $ 100 per year, due to the fact that therapy is based on generic retroviruses; while in Mexico the cost is up to $ 2,000 to be based on patented medicines.
Sierra said that the HIV patient in Mexico, besides stigma and discrimination, has to face an unfriendly health system to follow the treatment.
"Unfortunately, we have a fragmented health system and it is not very useful for people with illnesses to be treated for life, sometimes institutions are a barrier to the necessary continuity in the treatment of HIV," he said.
The photo project that will make you see HIV with different eyes